Jagsonpal Pharmaceuticals Share Price

NSE
214.02
-9.67 (4.12%)
JAGSNPHARM • 19 Jun, 2025 | 03:29 PM
BUY

1Y Annualised Return

64.70%

3Y Annualised Return

29.82%

5Y Annualised Return

73.73%

The current prices are delayed, login or Open Demat Account for live prices.

Jagsonpal Pharmaceuticals SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹91,47,506 (+40.73%)

Daily SIP of 25,000 would have become 91,47,506 in 1 year with a gain of 26,47,506 (+40.73%)

Jagsonpal Pharmaceuticals Stock Performance
Today’s Low - High
213.97
225.40
213.97
225.40
52 Week Low - High
130.48
328.04
130.48
328.04

Open

223.69

Prev. Close

223.69

Total Traded Value

1.47 Cr

View details of Market Depth
Jagsonpal Pharmaceuticals Fundamental

Market Cap (in crs)

1,486.95

Face Value

2

Turnover (in lacs)

146.93

Key Metrics
Qtr Change %
34.63% Fall from 52W High
-1.1
Dividend yield 1yr %
Above industry Median
0.9

Jagsonpal Pharmaceuticals shareholding Pattern

Promoter
67.8%
Foreign Institutions
2.1%
Public
30.1%
Promoter
67.8%
Foreign Institutions
2.1%
Public
30.1%
Promoter
68%
Foreign Institutions
2.3%
Mutual Funds
0.1%
Domestic Institutions
0.1%
Public
29.6%
Promoter
68%
Foreign Institutions
1.1%
Domestic Institutions
0.8%
Public
30%
Promoter
68.1%
Foreign Institutions
0.7%
Domestic Institutions
0.9%
Public
30.3%
Promoter
68.5%
Foreign Institutions
0.5%
Domestic Institutions
0.9%
Public
30.2%

Jagsonpal Pharmaceuticals Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
214.02
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5Day EMA
223.50
10Day EMA
226.90
12Day EMA
227.30
20Day EMA
227.50
26Day EMA
227.00
50Day EMA
225.80
100Day EMA
224.20
200Day EMA
213.80
5Day SMA
225.30
10Day SMA
229.60
20Day SMA
229.80
30Day SMA
224.50
50Day SMA
224.40
100Day SMA
225.20
150Day SMA
234.20
200Day SMA
221.10
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
17136 Rs
44651 Rs
Week Rs
41991 Rs
91145 Rs
Month Rs
73179 Rs
190107 Rs
Resistance & Support
217.94
Pivot
Resistance
First Resistance
221.90
Second Resistance
229.37
Third Resistance
233.33
Support
First Support
210.47
Second support
206.51
Third Support
199.04
Relative Strength Index
40.08
Money Flow Index
36.59
MACD
0.27
MACD Signal
2.17
Average True Range
9.96
Average Directional Index
18.94
Rate of Change (21)
2.81
Rate of Change (125)
-24.86

Jagsonpal Pharmaceuticals Latest News

16 JUN 2025 | Monday

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

11 JUN 2025 | Wednesday

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

02 JUN 2025 | Monday

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

View More

Jagsonpal Pharmaceuticals Company background

Founded in: 1978
Managing director: Manish Gupta
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multipurpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy and B Spofola, Czechoslovakia to manufacture sophisticated drugs in India. It has tied up with another Israelbased company, Makhteshim Chemical Works, for acquiring the marketing rights of an antioxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Companys RD activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. Its RD activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the companys sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021.On June 27, 2022, Infinity Holdings, an Indiafocused investment group acquired control over the Company consequent to acquisition of 43.73% of equity capital and became Promoters of the Company. The Company identified several products as part of new launches such as Indocap Gel, Lycored Plus, MemUp, Queezy ER to enhance healthcare professionals confidence and improve patient outcomes in 202324. It acquired the India and Bhutan business of Yash Pharma in May, 2024.

As of 19 Jun, 2025, Jagsonpal Pharmaceuticals share price is ₹214.4. The stock opened at ₹223.7 and had closed at ₹223.7 the previous day. During today’s trading session, Jagsonpal Pharmaceuticals share price moved between ₹213.97 and ₹225.40, with an average price for the day of ₹219.00. Over the last 52 weeks, the stock has recorded a low of ₹130.48 and a high of ₹328.04. In terms of performance, Jagsonpal Pharmaceuticals share price has declined by 22.1% over the past six months and has increased by 64.70% over the last year.

Read More

Jagsonpal Pharmaceuticals FAQs

Jagsonpal Pharmaceuticals share price is ₹214.02 in NSE and ₹214 in BSE as on 19/6/2025.

Jagsonpal Pharmaceuticals share price in the past 1-year return was 57.88. The Jagsonpal Pharmaceuticals share hit a 1-year low of Rs. 130.48 and a 1-year high of Rs. 328.04.

The market cap of Jagsonpal Pharmaceuticals is Rs. 1486.95 Cr. as of 19/6/2025.

The PE ratios of Jagsonpal Pharmaceuticals is 37.42 as of 19/6/2025.

The PB ratios of Jagsonpal Pharmaceuticals is 6.19 as of 19/6/2025

You can easily buy Jagsonpal Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Jagsonpal Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -